Point of Care lipid Test Market By Product Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

List of Tables

The global point of care lipid test market accounted for $284.86 million in 2021 and is expected to reach $426.58 million by 2031, registering a CAGR of 4.1% from 2022 to 2031.

Point of care (POC) test is one of the medical tests that assist in identifying chronic complications inside the human body. This means that, in contrast to other traditional diagnostic procedures, point-of-care testing assists in quickly diagnosing issues and shorten hospital stays. The point-of-care diagnostics assists in delivering real-time results in a matter of minutes. Point of care (POC) lipid test is performed to determine how well the lipids in the cells are working. When cholesterol levels rise, it changes how lipids work in the body and, as a result, can cause serious ailments such as heart attacks and coronary artery disease.

It is estimated that point of care lipid test market is expected to experience significant market growth during the forecast period owing to the rise in awareness on medical therapeutics on a global scale. In addition, increase in number of patients suffering from cardiovascular diseases, obesity, and other diseases further propel the growth of the market. However, rising cost associated with R&D of point of care lipid test is expected to impede the market growth. . In contrast, big investments in healthcare sector infrastructure and need for advancement in technology are anticipated to provide significant growth opportunities for the point of care lipid test market.

The Point of care lipid test market is segmented on the basis of product type, application, end user, and region. Depending on product, the market is classified into devices and consumables. On the basis of application, the market is divided into endogenous hyperlipidemia, combined hyperlipidemia , familial hypercholesterolemia, and others. By end user, the market is classified into hospitals & Clinics, diagnostics laboratories , and others.

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The report provides a comprehensive analysis of the key players that operate in the global point of care lipid test market. The key companies profiled in the report include Abbott Laboratories, Callegari, F. Hoffmann-La Roche Ltd., Menarini Group, Mico Bio Med, Nova Biomedical Corporation, SD biosensor, inc., Sinocare Inc., VivaChek Biotech (Hangzhou) Co.,Ltd, and Zoetis Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the point of care lipid test market analysis from 2021 to 2031 to identify the prevailing point of care lipid test market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the point of care lipid test market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global point of care lipid test market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

Devices
Consumables

By Application

Endogenous Hyperlipemia
Combined hyperlipidemia
Familial Hypercholesterolemia
Others

By End User

Hospitals and Clinics
Diagnostic Laboratories
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Abbott Laboratories
- Callegari
- F. Hoffmann-La Roche Ltd.
- Menarini Group
- Mico Bio Med
- Nova Biomedical Corporation
- SD Biosensor, Inc.
- Sinocare Inc.
- VivaChek Biotech (Hangzhou) Co.,Ltd
- Zoetis Inc.

Product Code: A14046

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Market dynamics
- 3.4.1.Drivers
  - 3.4.1.1. Surge in obesity in populace
  - 3.4.1.2. Increase in government initiatives to promote healthy lifestyle
  - 3.4.1.3. Increase in prevalence of cardiovascular disease and diabetes
- 3.4.2.Restraints
  - 3.4.2.1. High cost of product development
- 3.4.3.Opportunities
  - 3.4.3.1. Growth potential of emerging economies
3.5.COVID-19 Impact Analysis on the market

CHAPTER 4: POINT OF CARE LIPID TEST MARKET, BY PRODUCT TYPE

4.1 Overview
- 4.1.1 Market size and forecast
4.2. Devices
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
4.3. Consumables
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country

CHAPTER 5: POINT OF CARE LIPID TEST MARKET, BY APPLICATION

5.1 Overview
- 5.1.1 Market size and forecast
5.2. Endogenous Hyperlipemia
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
5.3. Combined hyperlipidemia
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
5.4. Familial Hypercholesterolemia
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market share analysis by country
5.5. Others
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market share analysis by country

CHAPTER 6: POINT OF CARE LIPID TEST MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2. Hospitals and Clinics
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
6.3. Diagnostic Laboratories
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country
6.4. Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market share analysis by country

CHAPTER 7: POINT OF CARE LIPID TEST MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product Type
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Key market trends, growth factors and opportunities
  - 7.2.5.1.2 Market size and forecast, by Product Type
  - 7.2.5.1.3 Market size and forecast, by Application
  - 7.2.5.1.4 Market size and forecast, by End User
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Key market trends, growth factors and opportunities
  - 7.2.5.2.2 Market size and forecast, by Product Type
  - 7.2.5.2.3 Market size and forecast, by Application
  - 7.2.5.2.4 Market size and forecast, by End User
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Key market trends, growth factors and opportunities
  - 7.2.5.3.2 Market size and forecast, by Product Type
  - 7.2.5.3.3 Market size and forecast, by Application
  - 7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product Type
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Key market trends, growth factors and opportunities
  - 7.3.5.1.2 Market size and forecast, by Product Type
  - 7.3.5.1.3 Market size and forecast, by Application
  - 7.3.5.1.4 Market size and forecast, by End User
  - 7.3.5.2 France
  - 7.3.5.2.1 Key market trends, growth factors and opportunities
  - 7.3.5.2.2 Market size and forecast, by Product Type
  - 7.3.5.2.3 Market size and forecast, by Application
  - 7.3.5.2.4 Market size and forecast, by End User
  - 7.3.5.3 UK
  - 7.3.5.3.1 Key market trends, growth factors and opportunities
  - 7.3.5.3.2 Market size and forecast, by Product Type
  - 7.3.5.3.3 Market size and forecast, by Application
  - 7.3.5.3.4 Market size and forecast, by End User
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Key market trends, growth factors and opportunities
  - 7.3.5.4.2 Market size and forecast, by Product Type
  - 7.3.5.4.3 Market size and forecast, by Application
  - 7.3.5.4.4 Market size and forecast, by End User
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Key market trends, growth factors and opportunities
  - 7.3.5.5.2 Market size and forecast, by Product Type
  - 7.3.5.5.3 Market size and forecast, by Application
  - 7.3.5.5.4 Market size and forecast, by End User
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Key market trends, growth factors and opportunities
  - 7.3.5.6.2 Market size and forecast, by Product Type
  - 7.3.5.6.3 Market size and forecast, by Application
  - 7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product Type
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Key market trends, growth factors and opportunities
  - 7.4.5.1.2 Market size and forecast, by Product Type
  - 7.4.5.1.3 Market size and forecast, by Application
  - 7.4.5.1.4 Market size and forecast, by End User
  - 7.4.5.2 China
  - 7.4.5.2.1 Key market trends, growth factors and opportunities
  - 7.4.5.2.2 Market size and forecast, by Product Type
  - 7.4.5.2.3 Market size and forecast, by Application
  - 7.4.5.2.4 Market size and forecast, by End User
  - 7.4.5.3 India
  - 7.4.5.3.1 Key market trends, growth factors and opportunities
  - 7.4.5.3.2 Market size and forecast, by Product Type
  - 7.4.5.3.3 Market size and forecast, by Application
  - 7.4.5.3.4 Market size and forecast, by End User
  - 7.4.5.4 Australia
  - 7.4.5.4.1 Key market trends, growth factors and opportunities
  - 7.4.5.4.2 Market size and forecast, by Product Type
  - 7.4.5.4.3 Market size and forecast, by Application
  - 7.4.5.4.4 Market size and forecast, by End User
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Key market trends, growth factors and opportunities
  - 7.4.5.5.2 Market size and forecast, by Product Type
  - 7.4.5.5.3 Market size and forecast, by Application
  - 7.4.5.5.4 Market size and forecast, by End User
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Key market trends, growth factors and opportunities
  - 7.4.5.6.2 Market size and forecast, by Product Type
  - 7.4.5.6.3 Market size and forecast, by Application
  - 7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product Type
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Key market trends, growth factors and opportunities
  - 7.5.5.1.2 Market size and forecast, by Product Type
  - 7.5.5.1.3 Market size and forecast, by Application
  - 7.5.5.1.4 Market size and forecast, by End User
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Key market trends, growth factors and opportunities
  - 7.5.5.2.2 Market size and forecast, by Product Type
  - 7.5.5.2.3 Market size and forecast, by Application
  - 7.5.5.2.4 Market size and forecast, by End User
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Key market trends, growth factors and opportunities
  - 7.5.5.3.2 Market size and forecast, by Product Type
  - 7.5.5.3.3 Market size and forecast, by Application
  - 7.5.5.3.4 Market size and forecast, by End User
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Key market trends, growth factors and opportunities
  - 7.5.5.4.2 Market size and forecast, by Product Type
  - 7.5.5.4.3 Market size and forecast, by Application
  - 7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

9.1 Abbott Laboratories
- 9.1.1 Company overview
- 9.1.2 Key Executives
- 9.1.3 Company snapshot
- 9.1.4 Operating business segments
- 9.1.5 Product portfolio
- 9.1.6 Business performance
- 9.1.7 Key strategic moves and developments
9.2 Callegari
- 9.2.1 Company overview
- 9.2.2 Key Executives
- 9.2.3 Company snapshot
- 9.2.4 Operating business segments
- 9.2.5 Product portfolio
- 9.2.6 Business performance
- 9.2.7 Key strategic moves and developments
9.3 F. Hoffmann-La Roche Ltd.
- 9.3.1 Company overview
- 9.3.2 Key Executives
- 9.3.3 Company snapshot
- 9.3.4 Operating business segments
- 9.3.5 Product portfolio
- 9.3.6 Business performance
- 9.3.7 Key strategic moves and developments
9.4 Menarini Group
- 9.4.1 Company overview
- 9.4.2 Key Executives
- 9.4.3 Company snapshot
- 9.4.4 Operating business segments
- 9.4.5 Product portfolio
- 9.4.6 Business performance
- 9.4.7 Key strategic moves and developments
9.5 Mico Bio Med
- 9.5.1 Company overview
- 9.5.2 Key Executives
- 9.5.3 Company snapshot
- 9.5.4 Operating business segments
- 9.5.5 Product portfolio
- 9.5.6 Business performance
- 9.5.7 Key strategic moves and developments
9.6 Nova Biomedical Corporation
- 9.6.1 Company overview
- 9.6.2 Key Executives
- 9.6.3 Company snapshot
- 9.6.4 Operating business segments
- 9.6.5 Product portfolio
- 9.6.6 Business performance
- 9.6.7 Key strategic moves and developments
9.7 SD Biosensor, Inc.
- 9.7.1 Company overview
- 9.7.2 Key Executives
- 9.7.3 Company snapshot
- 9.7.4 Operating business segments
- 9.7.5 Product portfolio
- 9.7.6 Business performance
- 9.7.7 Key strategic moves and developments
9.8 Sinocare Inc.
- 9.8.1 Company overview
- 9.8.2 Key Executives
- 9.8.3 Company snapshot
- 9.8.4 Operating business segments
- 9.8.5 Product portfolio
- 9.8.6 Business performance
- 9.8.7 Key strategic moves and developments
9.9 VivaChek Biotech (Hangzhou) Co.,Ltd
- 9.9.1 Company overview
- 9.9.2 Key Executives
- 9.9.3 Company snapshot
- 9.9.4 Operating business segments
- 9.9.5 Product portfolio
- 9.9.6 Business performance
- 9.9.7 Key strategic moves and developments
9.10 Zoetis Inc.
- 9.10.1 Company overview
- 9.10.2 Key Executives
- 9.10.3 Company snapshot
- 9.10.4 Operating business segments
- 9.10.5 Product portfolio
- 9.10.6 Business performance
- 9.10.7 Key strategic moves and developments